Company:  REVANCE THERAPEUTICS, INC ... (RVNC)
Form Type:  8-K
Filing Date:  10/11/2018 
CIK:  0001479290 
Address:  7555 GATEWAY BLVD. 
City, State, Zip:  NEWARK, California 94560 
Telephone:  510-742-3400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$15.36  
Change: 
-0.11 (-0.71%)  
Trade Time: 
02:22 PM EST  
Market Cap: 
$676.28M
Trade RVNC now with 

© 2019  
Description of Business
Revance Therapeutics, Inc. ("we" or "the Company") is a clinical-stage biotechnology company focused on the development, manufacturing and commercialization of novel neuromodulators for multiple aesthetic and therapeutic indications. We are leveraging our proprietary portfolio of botulinum toxin type A compounds, formulated with our patented and proprietary peptide technology, to address unmet needs in large and growing neuromodulator markets. Our initial focus is on developing daxibotulinumtoxinA, our highly purified botulinum toxin Type A, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles, muscle disorders, and chronic migraine. Our lead drug candidate is DaxibotulinumtoxinA for Injection ("DAXI"). We used our unique proprietary peptide excipient technology to formulate DAXI.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ...
    SIGNATURES